unknown
Stage
1
Investors
About
Cellbricks develops a patented bioprinting process to manufacture in‑vitro tissue models, personalized implants and organ-replacement constructs by printing multiple cell types into tissue-like structures with integrated vasculature.
Explore Cellbricks's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.